Craig B. Thompson, MD
Abramson Cancer Center
University of Pennsylvania Health System
Dr. Thompson is a respected clinician in hematologic malignancies and has contributed to the development of innovative treatments for autoimmune diseases and leukemia. As an internationally renowned researcher, he has focused on genes that control programmed cell death (apoptosis) and how the misregulation of such genes can contribute to cancer. He and his lab have pioneered the study of the BCL2 family of oncogenes and their role in regulating cell survival. Based on this research, future treatments could be designed to block the ability of cancer cells to survive. Better understanding of how apoptosis is regulated may also generate preventive treatments for individuals predisposed to cancer.
Programmed Cell Death: Apoptosis, Autophagy, and Necrosis
Cancer Center Director Michelle Le Beau, PhD, and Craig B. Thompson, MD